Immunovant, Inc. (IMVT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -95.06M | -92.33M | -102.52M | -117.41M | -110.64M | -100.39M | -88.65M | -76.2M | -59.7M | -47.1M | -60.06M | -47.37M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 14.08% | 8.03% | -15.64% | -54.08% | -85.32% | -113.15% | -47.6% | -60.86% | -7% | -1.52% | -197.53% | 28.03% |
| Net Income | -147.86M | -110.64M | -126.5M | -120.61M | -106.45M | -111.12M | -109.12M | -87.15M | -75.32M | -51.42M | -58.66M | -73.94M |
| Depreciation & Amortization | 96K | 101K | 105K | 107K | 109K | 99K | 89K | 80K | 64K | 58K | 349K | 343K |
| Stock-Based Compensation | 11.14M | 12.71M | 13.36M | 18.51M | 11.69M | 11.65M | 12.69M | 13.46M | 9.68M | 10.22M | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 26K | 25K | 24K | 24K | 22K | 23K | 22K | 66K | 252K | 295K | 10.53M | 10.69M |
| Working Capital Changes | 41.53M | 5.47M | 10.5M | -15.44M | -16.01M | -1.04M | 7.67M | -2.65M | 5.63M | -6.25M | -12.28M | 15.54M |
| Change in Receivables | -1.82M | 319K | -25K | 129K | -176K | -197K | 417K | 2.93M | -4.12M | 266K | -561K | -142K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.35M | 1.56M | -1.06M | -9.4M | -2.3M | -260K | 9.37M | 3.88M | 3.39M | -3.7M | -18.91M | 25.01M |
| Cash from Investing | -8K | 0 | 0 | 0 | -201K | -180K | -196K | -182K | -150K | -131K | -34K | -45K |
| Capital Expenditures | -8K | 0 | 0 | 0 | -201K | -180K | -196K | -182K | -150K | -131K | -34K | -45K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.64M | 564.6M | 24.59M | 2.92M | 450.61M | 2.46M | 730K | 686K | 1.54M | 469.84M | 148K | 890K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3.56M | 564.6M | 24.59M | 2.92M | 450M | 0 | 730K | 686K | 474.29M | -2.9M | 148K | 890K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 82K | 0 | 0 | 0 | 612K | 2.46M | 0 | 0 | -472.75M | 472.75M | 0 | 0 |
| Net Change in Cash | -92.42M | 472.65M | -77.04M | -115.06M | 339.29M | -98.26M | -87.06M | -75.36M | -55.57M | 421.01M | -60.03M | -46.57M |
| Free Cash Flow | -95.07M | -92.33M | -102.52M | -117.41M | -110.84M | -100.57M | -88.84M | -76.38M | -59.85M | -47.23M | -60.09M | -47.41M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 14.23% | 8.2% | -15.39% | -53.72% | -85.2% | -112.94% | -47.84% | -61.09% | -7.22% | -1.58% | -197.24% | 28.01% |
| FCF per Share | -0.47 | -0.51 | -0.59 | -0.69 | -0.73 | -0.68 | -0.61 | -0.52 | -0.41 | -0.33 | -0.46 | -0.36 |
| FCF Conversion (FCF/Net Income) | 0.64x | 0.83x | 0.81x | 0.97x | 1.04x | 0.90x | 0.81x | 0.87x | 0.79x | 0.92x | 1.02x | 0.64x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | -51K | 0 | 0 | 0 | 901K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |